Akèy › Maladi renn
Etid klinik pou Maladi renn ap rekrite nan Etazini
49 etid pou Maladi renn ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Atlanta, GA11 etid
- Houston, TX8 etid
- Orlando, FL7 etid
- Miami, FL6 etid
- Cedar Rapids, IA5 etid
- Philadelphia, PA5 etid
- New York City, NY5 etid
- Durham, NC5 etid
- Dallas, TX5 etid
- Los Angeles, CA4 etid
- Mountain View, CA4 etid
- Boston, MA4 etid
- Winston-Salem, NC4 etid
- Washington, DC4 etid
- Denver, CO4 etid
- Nashville, TN4 etid
- Albuquerque, NM3 etid
- Birmingham, AL3 etid
- Baltimore, MD3 etid
- San Francisco, CA3 etid
- Richmond, VA3 etid
- Indianapolis, IN3 etid
- Phoenix, AZ3 etid
- Ann Arbor, MI3 etid
- Chicago, IL3 etid
- Salt Lake City, UT3 etid
- Pembroke Pines, FL3 etid
Pa eta
- Alabama3 etid
- Arizona4 etid
- Colorado6 etid
- Florid12 etid
- Georgia13 etid
- Illinois5 etid
- Indiana3 etid
- Iowa5 etid
- Kalifòni13 etid
- Maryland6 etid
- Massachusetts5 etid
- Michigan7 etid
- Minnesota4 etid
- Missouri4 etid
- New Jersey5 etid
- New Mexico3 etid
- New York6 etid
- North Carolina9 etid
- Pennsylvania5 etid
- Tennessee6 etid
- Texas11 etid
- Utah3 etid
- Virginia5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06963827An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
Ap rekriteFaz 2
Laj 18 a 115 · Tout sèks · Mizajou Sep 30, 2026 · NCT06664814Autonomic and Renal Contributions to Hypertension With ADT
Ap rekriteFaz 4Volontè an sante akeyi
Laj 40 ak plis · Gason · Mizajou Sep 30, 2026 · NCT07848828Immune System Related Kidney Disease
Ap rekriteEtid obsèvasyon
Laj 10 a 99 · Tout sèks · Mizajou Sep 28, 2026 · NCT00001979A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Ap rekriteFaz 2
Laj 18 a 60 · Tout sèks · Mizajou Sep 25, 2026 · NCT07541287Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Ap rekriteFaz 2
Laj 18 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT00977977Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
Ap rekriteFaz 3
Laj 2 a 18 · Tout sèks · Mizajou Sep 21, 2026 · NCT07498335Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06798909A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06525636PS-002 for the Treatment of IgA Nephropathy in Adults
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07182227Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06374537The Effects of the CF Carrier State on the Kidneys and Pancreas
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT05474417Duke APOL1 Research Biorepository
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT04160507Enhancing Physical Function in Older Adults With Chronic Kidney Disease
Ap rekrite
Laj 65 a 100 · Tout sèks · Mizajou Aug 26, 2026 · NCT06738394A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT07006831Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Aug 17, 2026 · NCT06858319Pedal Pump Clinical Trial on Edema V1
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT07760363Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07187479Cooperative Assessment of Late Effects for SCD Curative Therapies
Ap rekriteEtid obsèvasyon
Laj 4 a 65 · Tout sèks · Mizajou Jul 27, 2026 · NCT05153967NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Jul 24, 2026 · NCT06810622Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jul 6, 2026 · NCT06613568Atacicept in Multiple Glomerular Diseases
Ap rekriteFaz 2
Laj 2 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT06983028A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jun 25, 2026 · NCT05696613SPYRAL GEMINI Pilot Study
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jun 24, 2026 · NCT06907147Study of BHV-1400 in IgA Nephropathy
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Jun 23, 2026 · NCT07054684Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.